Aveanna Healthcare (AVAH)
(Delayed Data from NSDQ)
$3.71 USD
+0.44 (13.46%)
Updated Aug 6, 2024 04:00 PM ET
After-Market: $3.70 -0.01 (-0.27%) 7:58 PM ET
3-Hold of 5 3
A Value A Growth A Momentum A VGM
Income Statements
Fiscal Year end for Aveanna Healthcare Holdings Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 1,895 | 1,788 | 1,679 | 1,495 | 1,384 |
Cost Of Goods | 1,300 | 1,234 | 1,136 | 1,041 | 965 |
Gross Profit | 595 | 553 | 542 | 455 | 419 |
Selling & Adminstrative & Depr. & Amort Expenses | 587 | 1,196 | 579 | 458 | 380 |
Income After Depreciation & Amortization | 8 | -642 | -36 | -3 | 39 |
Non-Operating Income | 6 | 86 | -9 | 35 | -22 |
Interest Expense | 153 | 108 | 69 | 83 | 92 |
Pretax Income | -139 | -664 | -114 | -52 | -75 |
Income Taxes | -4 | -2 | 3 | 5 | 1 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -135 | -662 | -117 | -57 | -77 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -135 | -662 | -117 | -57 | -77 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 148 | 80 | 126 | 110 | 73 |
Depreciation & Amortization (Cash Flow) | 140 | 722 | 162 | 113 | 34 |
Income After Depreciation & Amortization | 8 | -642 | -36 | -3 | 39 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 189.96 | 185.55 | 170.63 | NA | NA |
Diluted EPS Before Non-Recurring Items | -0.16 | -0.08 | 0.42 | NA | NA |
Diluted Net EPS (GAAP) | -0.71 | -3.57 | -0.69 | NA | NA |
Fiscal Year end for Aveanna Healthcare Holdings Inc falls in the month of December .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | NA | 490.65 | 478.84 | 478.01 | 471.95 |
Cost Of Goods | NA | 344.80 | 330.39 | 330.75 | 316.69 |
Gross Profit | NA | 145.85 | 148.45 | 147.26 | 155.26 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 122.99 | 119.15 | 223.62 | 117.76 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | 22.86 | 29.30 | -76.36 | 37.50 |
Non-Operating Income | NA | 18.27 | -21.18 | 14.19 | 25.28 |
Interest Expense | NA | 39.65 | 39.70 | 39.60 | 37.99 |
Pretax Income | NA | 1.49 | -31.60 | -101.76 | 24.79 |
Income Taxes | NA | 12.66 | -5.86 | 0.63 | -0.81 |
Minority Interest | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | -11.17 | -25.74 | -102.39 | 25.60 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | -11.17 | -25.74 | -102.39 | 25.60 |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | NA | 192.24 | 190.93 | 189.14 | 189.74 |
Diluted EPS Before Non-Recurring Items | NA | -0.05 | -0.02 | -0.05 | -0.02 |
Diluted Net EPS (GAAP) | NA | -0.06 | -0.13 | -0.54 | 0.13 |